Pharmaceutical Distributors in India

A foreign principal usually registers through a local affiliate or importer, then appoints CFA warehouses and stockists by state rather than one exclusive national agent. Those stockists invoice tens of thousands of retail chemists on credit; margins are thin and competition is about fill rates, bounce cheques and how fast a short-dated SKU comes back. Entero and a handful of listed or private consolidators have been buying those books, which changes who a brand negotiates with in Pune versus Coimbatore. Public volume is a different desk: TNMSC, Karnataka’s KMSCL, Rajasthan Medical Services Corporation and their peers run e-tenders, hold buffer stock and feed district warehouses. HLL Lifecare sits on devices, contraceptives and selected hospital lines that never touch a private chemist. CGHS dispensaries in Delhi, NCR and other cities indent on a central rate contract that is not a state corporation tender. Jan Aushadhi stores buy through PMBI, so a generic house can win a chemist and still lose the government generic aisle. MedPlus warehouses supply its own stores and, in some cities, neighbouring independents — treat that overlap as a fact, not a footnote. Mumbai’s Masjid Bunder and Delhi’s Bhagirath Palace still move cash lots to small chemists that never open a principal’s portal. Cold chain for vaccines and biologics concentrates in Bhiwandi, Hyderabad, Bengaluru and the NCR, with 3PLs filling the lanes the manufacturer fleet will not run daily. Name the state, the buyer type and whether the SKU is chemist, Jan Aushadhi or hospital — a single “national distributor” slide is how Indian coverage gaps get hidden.

The accounts above are the ones our field teams and analysts work with. What a brand team typically commissions from us in India:

Matching listicle and country brief, sibling directories in India, and the same directory for neighbouring markets.